USC Roski Eye Institute Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • USC Roski Eye Institute's estimated annual revenue is currently $25.4M per year.(i)
  • USC Roski Eye Institute's estimated revenue per employee is $270,000

Employee Data

  • USC Roski Eye Institute has 94 Employees.(i)
  • USC Roski Eye Institute grew their employee count by 6% last year.

USC Roski Eye Institute's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is USC Roski Eye Institute?

The USC Roski Eye Institute, Keck School of Medicine, with full-time faculty physicians covering all subspecialties of ophthalmology. In 1974, the USC Keck School of Medicine established the USC Department of Ophthalmology, which grew into the USC Roski Eye Institute, becoming an essential regional, national and global leader in the field. Recognized by U.S. News & World Report and Ophthalmology Times, The USC Roski Eye Institute and the Department of Ophthalmology has been ranked in the top 10 ophthalmology programs in the country for the past 26 years. The USC Roski Eye Institute is headquartered near downtown Los Angeles and has clinics in Pasadena, and Arcadia. For more information, visit eye.keckmedicine.org. OUR VISION IS OUR MISSION PROTECTING USC Roski Eye Institute leads major research in the epidemiology of eye disease to help prevent blindness. PRESERVING USC Roski Eye Institute diagnoses, treats and manages the most complex eye conditions, from in utero to advanced age. RESTORING USC Roski Eye Institute integrates and applies emerging technologies to develop new methods to restore sight to the blind. We have made it our mission to restore sight and make dramatic improvements in the quality of our patients’ lives. Major breakthroughs • Changing health care policy in America -our world-renowned community health studies assess eye diseases for to treatment and prevention initiatives • Pioneered use of ultra-high speed Fournier domain optical coherence tomography (OCT) for advanced diagnosis • Invention of the world’s first FDA approved artificial retina, Argus II- brought an unprecedented degree of sight back to those with a form of retinal blindness • Discovery of a new stem cell therapy for age-related macular degeneration • Discovered which retinal cells mutate to become retinoblastoma-the most common type of eye cancer in children

keywords:N/A

N/A

Total Funding

94

Number of Employees

$25.4M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.7M9425%N/A
#2
$19.7M94N/AN/A
#3
$14.1M9422%N/A
#4
$23.5M94109%N/A
#5
$3.5M9452%N/A